Table of Contents
ISRN Dermatology
Volume 2011 (2011), Article ID 384729, 8 pages
http://dx.doi.org/10.5402/2011/384729
Clinical Study

Prognostic Variables and Surgical Management of Foot Melanoma: Review of a 25-Year Institutional Experience

1Department of Surgery, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA 23298-0645, USA
2Department of Pathology, Virginia Commonwealth University and the Massey Cancer Center, Richmond, VA 23298-0662, USA

Received 18 April 2011; Accepted 15 May 2011

Academic Editors: A. Firooz and A. Zalewska

Copyright © 2011 Omar M. Rashid et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Introduction. Cutaneous foot melanoma is rare, challenging to manage, and not adequately examined in the literature. This study evaluated the prognostic variables and surgical management of foot melanoma. Materials and Methods. Foot melanoma cases managed at an academic center from 1985 to 2010 were retrospectively reviewed. Results. 46 patients were identified with a broad range of demographic characteristics. Overall recurrence was 32.6%: 19% acral lentiginous, 57% nodular, 66% superficial spreading, 30% melanoma unspecified, 50% severely atypical; 53% ulcerated, 23% nonulcerated; 29% on the dorsum of the foot, 17% heel, 60% ankle, 22% toe, 50% plantar; 0% <1 mm thick, 47% 1–4 mm, 33% >4 mm. 13 had positive nodes, 4 (31%) of whom recurred. Prognostic factors and recurrence did not correlate, and survival was 96% with a median followup of 91 months. Conclusions. Aggressive management of foot melanoma may result in excellent long-term survival even following disease recurrence.